UK lags EU in authorising new medicines after Brexit

11 comments
  1. >The UK fell behind the EU within the race to draw modern medicines to be used within the nation within the first yr after Brexit, researchers have discovered.
    >
    >An audit of approvals issued by the UK’s medicines regulator performed by Imperial College, London discovered that solely 35 so-called novel medicines had been accepted to be used within the UK in 2021 in contrast with 40 within the EU and 52 within the US.
    >
    >Industry consultants stated the smaller dimension of the UK market, now that it was regulated independently from the EU, coupled with the complexity of coping with the NHS had been more likely to be key components explaining the shortfall.

    Another example of ‘project fear’ becoming project reality.

  2. Good. These things need to be done carefully and methodically.

    If the UK was authorising them faster you lot would be complaining about cutting corners.

  3. My family has been affected by this.
    Most medicines and treatments are not available and you have to travel abroad for any kind of treatment.

    It’s a lot worse than you think.
    I would say only 10 percent of drugs are actually availabe because it has to be approved by disease.

    Very frustrating.

  4. Brace for “The right honourable gentleman is malicious and bonkers, we had TEH FASTEST vacine rollout in TEH world” blah blah blah

  5. That time the European Medicines Agency sent back the AZ vaccine request for approval to get them to add more vaccine. The dose they were flogging to the EU was half the measure they promised according to EMA measurements. That was the version that the UK bought.

    ‘Yeah but it went early’ – Boris, prolly.

  6. Politicians don’t care abut people’s needs. Only their own desires. So we’ll have to wait til people start dying, then the papers will pick it up to sell a story, and politicians will waste 100x more resources on jumping to save their reputations. And the cycle continues.

Leave a Reply